A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 15, 2013

Primary Completion Date

June 13, 2017

Study Completion Date

June 13, 2017

Conditions
Juvenile Idiopathic Arthritis
Interventions
DRUG

Tocilizumab

Subcutaneous 162 mg dose QW or Q2W for 52 weeks

Trial Locations (42)

1270

Hospital Gral de Niños Pedro Elizalde, Buenos Aires

2145

Westmead Hospital; Paediatric Rheumatology, Westmead

3052

Royal Children'S Hospital; Paediatric Rheumatology, Parkville

5000

Hospital de Ninos de la Santisima Trinidad; Reumatologia Infantil, Córdoba

13353

Charité Campus; Virchow Klinikum Berlin, Berlin

16147

Istituto Giannina Gaslini-Ospedale Pediatrico IRCCS, Genoa

27710

Duke University, Durham

28009

Hospital Infantil Universitario Niño Jesus, Servicio Reumatologia, Madrid

28034

Hospital Ramon y Cajal ; Servicio de Reumatologia, Madrid

28046

Hospital de La Paz; Unidad de Reumatologia Pediatrica, Madrid

28203

Levine Children's Hospital; Divison of Pediatric Rheumatology; Department of Pediatrics, Charlotte

44195

Cleveland Clinic Fndn, Cleveland

46026

Hospital Universitario la Fe: Servicio de Reumatologia Pediatrica, Valencia

50139

Nuovo Ospedale Pediatrico Meyer; Reumatologia - Clinica Pediatrica 1°, Florence

53757

Asklepios Klinik; Zentrum fuer Allgemeine Paediatrie und Neonatologie, Sankt Augustin

60611

Ann & Robert H. Lurie Children's Hospital of Chicago; Division of Rheumatology, Chicago

60649

The University of Chicago;Department of Pediatrics, Chicago

64460

Hospital Universitario Dr. Jose Eleuterio Gonzalez; Pediatria, Monterrey

72202

Arkansas Children's Hospital Research Institute, Little Rock

79106

Uniklinikum Freiburg Zentrum für Kinder- und Jugendmedizin; Pädiatrische Infektio- u. Rheumatologie, Freiburg im Breisgau

84109

University of Utah; Immunology/Rheumatology/Allergy, Salt Lake City

94275

CH de Bicêtre; Pediatrie Generale, Le Kremlin-Bicêtre

98105

Seattle Children's Hospital, Seattle

115522

"FSBI Scientific Research Institute of Rheumatology of russian Academy of Medical Sciences", Moscow

119991

SI Sceintific children health center RAMS, Moscow

06106

Connecticut Children's Medical Center; 5E Clinical Trials Unit, Hartford

07601

Hackensack University Medical Center; Pediatric Rheumatology, Hackensack

45229-3039

Cincinnati Children'S Hospital Medical Center; Division of Rheumatology, Cincinnati

14048-900

Hospital das Clinicas - FMUSP Ribeirao Preto; Pediatria - Imunologia e Reumatologia, Ribeirão Preto

05403-000

Hospital das Clinicas - FMUSP; Instituto da Crianca - Reumatologia, São Paulo

22793-080

Universidade Federal de Sao Paulo - UNIFESP, São Paulo

T3B 6A8

Alberta Children'S Hospital, Calgary

K1H 8L1

Children'S Hospital of Eastern Ontario, Ottawa

M5G 1X8

Hospital For Sick Children, Toronto

00165

Irccs Ospedale Pediatrico Bambin Gesu - Dip. Di Medicina, Rome

06720

"Hospital Infantil de México Federico Gomez; Rheumatology", México

06700

Cliditer SA de CV, Miexico City

08950

Hospital Sant Joan De Deu; Servicio de Reumatologia Pediatrica, Esplugas de Llobregat

BS2 8BJ

Bristol Royal Hospital For Children, Bristol

L12 2AP

Alder Hey Children's NHS Foundation Trust, Liverpool

WC1N 3JH

Great Ormond Street Hospital; Somers Clinical Research Facility, London

NG7 2UH

Nottingham Children's Hospital, Nottingham

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01904292 - A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis | Biotech Hunter | Biotech Hunter